497 related articles for article (PubMed ID: 8626358)
1. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
[TBL] [Abstract][Full Text] [Related]
2. Nefazodone: aspects of efficacy.
Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
4. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
5. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
Zajecka JM
J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
[TBL] [Abstract][Full Text] [Related]
6. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Marcus RN; Mendels J
J Clin Psychiatry; 1996; 57 Suppl 2():19-23. PubMed ID: 8626359
[TBL] [Abstract][Full Text] [Related]
7. Efficacy in long-term treatment of depression.
Montgomery SA
J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
[TBL] [Abstract][Full Text] [Related]
8. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer E; Feighner J; Mandos LA; Rickels K
J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic dose range of nefazodone in the treatment of major depression.
Robinson DS; Marcus RN; Archibald DG; Hardy SA
J Clin Psychiatry; 1996; 57 Suppl 2():6-9. PubMed ID: 8626365
[TBL] [Abstract][Full Text] [Related]
10. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
Bakish D; Hooper CL; Thornton MD; Wiens A; Miller CA; Thibaudeau CA
Int Clin Psychopharmacol; 1997 Mar; 12(2):91-7. PubMed ID: 9219044
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Bremner JD
J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
[TBL] [Abstract][Full Text] [Related]
14. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
[TBL] [Abstract][Full Text] [Related]
15. The safety profile of nefazodone.
Robinson DS; Roberts DL; Smith JM; Stringfellow JC; Kaplita SB; Seminara JA; Marcus RN
J Clin Psychiatry; 1996; 57 Suppl 2():31-8. PubMed ID: 8626361
[TBL] [Abstract][Full Text] [Related]
16. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and safety: essentials in antidepressant pharmacotherapy.
Lader MH
J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
[TBL] [Abstract][Full Text] [Related]
18. An open-label trial of nefazodone in high comorbidity panic disorder.
DeMartinis NA; Schweizer E; Rickels K
J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
[TBL] [Abstract][Full Text] [Related]
20. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
